Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 01/28/13 - 12:25 pm
Tags:
Sanofi, Kynamro, Isis Pharmaceuticals, Regeneron, Eli Lilly, Pfizer, Merck
Statins Beware?
Motley Fool
Mon, 01/28/13 - 12:21 pm
Tags:
statins, PCSK9 inhibitors, Sanofi, Amgen, Pfizer, Roche, Regeneron
3 Biotech Growth Stocks Near Highs
Seeking Alpha
Sat, 01/12/13 - 10:45 am
Tags:
Celgene, Valiant, Regeneron
Banking on Biotech
CNBC
Sat, 01/12/13 - 10:33 am
Tags:
Regeneron, Biogen Idec, Acorda Therapeutics, Sanofi, Celgene, Alexion, Biomarin, NPS Pharmaceuticals, Cerner, EXACT Sciences, Pfizer, Bristol-Myers Squibb, Eli Lilly
10 Biotech Stocks With A History Of Beating Earning Expectations
TheStreet.com
Fri, 01/11/13 - 12:14 pm
Tags:
Alexion, Regeneron, Optimer, Targacept, Osiris, Array Biopharma, YM BioSciences, Questcor Pharmaceuticals, Charles River Laboratories, Illumina
JPMorgan Healthcare Conference Highlights: Regeneron Pharmaceuticals
Motley Fool
Wed, 01/9/13 - 10:02 am
Tags:
Regeneron, JPMHC 2013
Regeneron reports Q4 Eylea U.S. net sales $276M
The Fly on the Wall
Tue, 01/8/13 - 10:32 am
Tags:
Eylea, Regeneron, JPMHC 2013
Better Than Lipitor! Higher Sales?
Motley Fool
Tue, 01/1/13 - 11:53 am
Tags:
Pfizer, Lipitor, Juxtapid, Aegerion, Kynamro, Sanofi, Isis Pharmaceuticals, Regeneron, Alnylam, PCSK9 inhibitors
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Investopedia
Sat, 12/29/12 - 09:42 am
Tags:
Celgene Corporation, Regeneron, Gilead Sciences
Can Regeneron Continue To Generate Profits?
Seeking Alpha
Mon, 12/17/12 - 01:26 pm
Tags:
Regeneron
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Tags:
Xtandi, Medivation, prostate cancer, Stribild, Gilead Sciences, HIV, Belviq, Arena Pharmaceuticals, obesity, weight loss, Qsymia, Vivus, Kyprolis, ONYX Pharmaceuticals, Multiple Myeloma, Omontys, Affymax, anemia, Linzess, irritable bowel syndrome, Ironwood Pharmaceuticals, Bosulif, chronic myeloid leukemia, Pfizer, Amyvid, Alzheimer's disease, Eli Lilly, Eylea, macular degeneration, Regeneron
Regeneron says Eylea approved in European Union
Yahoo/AP
Tue, 11/27/12 - 11:17 am
Tags:
Eylea, Europe, Regeneron
This Week in Biotech
Motley Fool
Sun, 11/25/12 - 11:15 am
Tags:
Arena, Vivus, Regeneron, Sanofi, MAP Pharmaceuticals, Allergan
This Top-Dollar Drug Hits the Discount Rack
Motley Fool
Sat, 11/17/12 - 01:27 pm
Tags:
Sanofi, Dendreon, Regeneron, Zaltrap
New Drugs for Lipids Set Off Race
NY Times, NY
Tue, 11/6/12 - 12:07 pm
Tags:
PCSK9 inhibitors, Sanofi, Regeneron, Amgen, Pfizer, Roche
Regeneron, Sanofi Take Step Forward With Cholesterol Drug
Minyanville
Mon, 11/5/12 - 11:05 am
Tags:
Regeneron, Sanofi, PCSK9, LDL cholesterol, Amgen, AMG145, SAR236553/REGN727
Eyeing a Sandbagged Guidance
Motley Fool
Sun, 10/28/12 - 11:37 am
Tags:
Regeneron
This Week in Biotech
Motley Fool
Sun, 10/28/12 - 11:37 am
Tags:
Columbia Laboratories, United Therapeutics, Watson Pharmaceuticals, Regeneron, Alexion
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Tags:
Lpath, Pfizer, iSONEP, Asonept, macular degeneration, multiple sclerosis, MS, Regeneron, Roche, Bayer, Sanofi, Valeant Pharmaceuticals, GSK
Regeneron posts strong 3rd-quarter results on new approvals; raises Eylea sales estimate
Yahoo/AP
Wed, 10/24/12 - 11:55 am
Tags:
earnings, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.